Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong -- and History Is on Its Side.
Yahoo Finance ·
A 28% drop in Intuitive Surgical ( ISRG +5.72% ) stock this year has left investors anxious, but an analyst from Goldman Sachs argues the panic regarding the medical device maker is rooted in a misunderstanding of two major changes to Intuitive's instrument lifetimes. Several analysts downgraded their positions in Intuitive after its first-quarter earnings, including those with Deutsche Bank , Bank of America , JPMorgan Chase , and HSBC . David Roman of Goldman Sachs, on the other hand, upped the stock's price target to $558. Here is what changed, why the market reacted defensively, and what matters next. Intuitive recently adjusted the number of times that hospitals can reuse its surgical tools. While investors feared this would kill recurring revenue, the reality is more nuanced.
DYAX Investor Sentiment
Bullish (Long) 50% · Bearish (Short) 50%
478 participants
Related News
- Here is Why Jim Cramer Thinks Meta Platforms (META) is Misunderstood
- This Tech ETF Is Quietly Outperforming QQQ in 2026 -- Is There Still Time to Buy?
- Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives?
- 3 Core Artificial Intelligence (AI) Market Leaders to Buy with $1,000 Right Now and Hold for the Next 20 Years
- SA Asks: What's next for telecommunications stocks?
- Meta Could Hand Samsung Its Biggest AI Chip Order Yet in $6.5 Billion Deal